Michael Bozzella
Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cytomegalovirus Retinitis | 1 | 2022 | 17 | 0.820 |
Why?
| AIDS-Related Opportunistic Infections | 1 | 2022 | 116 | 0.760 |
Why?
| Anti-Bacterial Agents | 2 | 2021 | 1481 | 0.730 |
Why?
| Epiglottitis | 1 | 2020 | 4 | 0.690 |
Why?
| Vaping | 1 | 2020 | 45 | 0.640 |
Why?
| Electronic Nicotine Delivery Systems | 1 | 2020 | 71 | 0.620 |
Why?
| Pamphlets | 1 | 2018 | 24 | 0.620 |
Why?
| Infection Control | 1 | 2019 | 135 | 0.600 |
Why?
| Drug Resistance, Bacterial | 1 | 2018 | 155 | 0.580 |
Why?
| Cross Infection | 1 | 2019 | 197 | 0.570 |
Why?
| Intensive Care Units, Neonatal | 1 | 2019 | 176 | 0.560 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 191 | 0.550 |
Why?
| Antimicrobial Stewardship | 1 | 2018 | 94 | 0.540 |
Why?
| Staphylococcal Infections | 1 | 2019 | 340 | 0.490 |
Why?
| Ambulatory Care | 1 | 2018 | 478 | 0.480 |
Why?
| Microbiota | 1 | 2021 | 647 | 0.460 |
Why?
| Cystic Fibrosis | 1 | 2021 | 955 | 0.400 |
Why?
| Practice Patterns, Physicians' | 1 | 2018 | 1177 | 0.350 |
Why?
| Lung | 1 | 2021 | 3559 | 0.320 |
Why?
| Ganciclovir | 1 | 2022 | 49 | 0.210 |
Why?
| Anaerobiosis | 1 | 2021 | 49 | 0.190 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 72 | 0.190 |
Why?
| Cytomegalovirus | 1 | 2022 | 144 | 0.190 |
Why?
| Hoarseness | 1 | 2020 | 4 | 0.170 |
Why?
| Respiratory Function Tests | 1 | 2021 | 522 | 0.170 |
Why?
| Sputum | 1 | 2021 | 285 | 0.170 |
Why?
| District of Columbia | 1 | 2019 | 24 | 0.170 |
Why?
| Chlorhexidine | 1 | 2019 | 22 | 0.160 |
Why?
| RNA, Ribosomal, 16S | 1 | 2021 | 485 | 0.160 |
Why?
| Adolescent | 3 | 2022 | 17841 | 0.160 |
Why?
| Laryngoscopy | 1 | 2020 | 91 | 0.160 |
Why?
| Deglutition Disorders | 1 | 2020 | 118 | 0.150 |
Why?
| Longevity | 2 | 2009 | 137 | 0.150 |
Why?
| Child | 3 | 2022 | 18412 | 0.150 |
Why?
| Recombination, Genetic | 2 | 2008 | 176 | 0.140 |
Why?
| Antiviral Agents | 1 | 2022 | 645 | 0.140 |
Why?
| Humans | 9 | 2022 | 114662 | 0.130 |
Why?
| Health Services Research | 1 | 2018 | 371 | 0.130 |
Why?
| Longitudinal Studies | 1 | 2021 | 2387 | 0.120 |
Why?
| Fibroblasts | 2 | 2009 | 838 | 0.120 |
Why?
| United States | 2 | 2022 | 12181 | 0.120 |
Why?
| Patient Education as Topic | 1 | 2018 | 680 | 0.110 |
Why?
| Prospective Studies | 1 | 2021 | 6219 | 0.090 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 1183 | 0.090 |
Why?
| Mole Rats | 1 | 2009 | 5 | 0.080 |
Why?
| Infant | 1 | 2022 | 7961 | 0.080 |
Why?
| Infant, Newborn | 1 | 2019 | 5045 | 0.080 |
Why?
| Rodentia | 1 | 2008 | 44 | 0.080 |
Why?
| Genes, Tumor Suppressor | 1 | 2008 | 77 | 0.080 |
Why?
| Body Size | 1 | 2008 | 92 | 0.070 |
Why?
| Cell Transformation, Neoplastic | 1 | 2009 | 308 | 0.070 |
Why?
| DNA Repair | 1 | 2008 | 184 | 0.070 |
Why?
| Male | 2 | 2022 | 55583 | 0.070 |
Why?
| Young Adult | 1 | 2021 | 10466 | 0.070 |
Why?
| Cell Cycle | 1 | 2008 | 542 | 0.060 |
Why?
| Biological Evolution | 1 | 2008 | 416 | 0.060 |
Why?
| Female | 2 | 2021 | 59493 | 0.060 |
Why?
| Retrospective Studies | 1 | 2019 | 12546 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2009 | 3532 | 0.040 |
Why?
| DNA Breaks, Double-Stranded | 2 | 2008 | 29 | 0.040 |
Why?
| Genes, Reporter | 2 | 2008 | 257 | 0.040 |
Why?
| Neoplasms | 1 | 2009 | 2097 | 0.030 |
Why?
| Antigens, Polyomavirus Transforming | 1 | 2009 | 14 | 0.020 |
Why?
| Retinoblastoma Protein | 1 | 2009 | 52 | 0.020 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2009 | 57 | 0.020 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 69 | 0.020 |
Why?
| Rats, Inbred BN | 1 | 2008 | 52 | 0.020 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 228 | 0.020 |
Why?
| Chromosomes, Human | 1 | 2008 | 39 | 0.020 |
Why?
| Guinea Pigs | 1 | 2008 | 136 | 0.020 |
Why?
| Cricetinae | 1 | 2008 | 253 | 0.020 |
Why?
| Rats, Inbred F344 | 1 | 2008 | 241 | 0.020 |
Why?
| Cell Communication | 1 | 2009 | 279 | 0.020 |
Why?
| Cellular Senescence | 1 | 2008 | 152 | 0.020 |
Why?
| Telomerase | 1 | 2008 | 206 | 0.020 |
Why?
| Telomere | 1 | 2008 | 202 | 0.020 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2009 | 445 | 0.020 |
Why?
| Mice | 2 | 2009 | 14863 | 0.010 |
Why?
| Cell Line | 1 | 2008 | 2636 | 0.010 |
Why?
| Cell Proliferation | 1 | 2009 | 2186 | 0.010 |
Why?
| Models, Biological | 1 | 2008 | 1620 | 0.010 |
Why?
| Cells, Cultured | 1 | 2008 | 3885 | 0.010 |
Why?
| Rats | 1 | 2008 | 4958 | 0.010 |
Why?
| Mice, Inbred C57BL | 1 | 2008 | 4692 | 0.010 |
Why?
| Animals | 2 | 2009 | 31698 | 0.010 |
Why?
|
|
Bozzella's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|